Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
April 7, 2007
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy
Annechien Lambeck, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Plos One
|
December 24, 2010
A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease
Cristina Mitea, Elma M J Salentijn, Peter van Veelen, et al.
Proteomics
|
December 19, 2017
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface
Helena M Bijen, Chopie Hassan, Michel G D Kester, et al.
Frontiers in Immunology
|
June 1, 2023
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells
Willemijn van der Wulp, Anna M Gram, Boris Bleijlevens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2003
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
W A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.
Cancer Research
|
February 5, 2003
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter
Marij J P Welters, Annemieke de Jong, Susan J F van den Eeden, et al.
Journal of Autoimmunity
|
June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers
Wendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Vaccine
|
November 9, 2004
Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model
Marij J P Welters, Dmitri V Filippov, Susan J F van den Eeden, et al.
Blood Advances
|
January 17, 2025
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs
Noa A Linthorst, Yvonne K Jongejan, Richard J Dirven, et al.
The New England Journal of Medicine
|
November 6, 2009
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
Gemma G Kenter, Marij J P Welters, A Rob P M Valentijn, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
April 7, 2007
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy
Annechien Lambeck, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Plos One
|
December 24, 2010
A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease
Cristina Mitea, Elma M J Salentijn, Peter van Veelen, et al.
Proteomics
|
December 19, 2017
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface
Helena M Bijen, Chopie Hassan, Michel G D Kester, et al.
Frontiers in Immunology
|
June 1, 2023
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells
Willemijn van der Wulp, Anna M Gram, Boris Bleijlevens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2003
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
W A Erik Marijt, Mirjam H M Heemskerk, Freke M Kloosterboer, et al.
Cancer Research
|
February 5, 2003
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter
Marij J P Welters, Annemieke de Jong, Susan J F van den Eeden, et al.
Journal of Autoimmunity
|
June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers
Wendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Vaccine
|
November 9, 2004
Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model
Marij J P Welters, Dmitri V Filippov, Susan J F van den Eeden, et al.
Blood Advances
|
January 17, 2025
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs
Noa A Linthorst, Yvonne K Jongejan, Richard J Dirven, et al.
The New England Journal of Medicine
|
November 6, 2009
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
Gemma G Kenter, Marij J P Welters, A Rob P M Valentijn, et al.
Page
of 8